Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

BPC-157 Research Cycle Planning: Protocol Comparison

4 weeks on / 2 weeks off Twice daily (12-hour intervals) 2 weeks minimum Yes. Sufficient turnover for baseline restoration Acute injury models, short-term tissue repair studies Standard protocol. Balances observation window with receptor reset 6 weeks on / 4 w

This comparison does not assign a generated winner or score.

  • 4 weeks on / 2 weeks off
  • Twice daily (12-hour intervals)
  • 2 weeks minimum
  • Yes. Sufficient turnover for baseline restoration
  • Acute injury models, short-term tissue repair studies
  • Standard protocol. Balances observation window with receptor reset
  • 6 weeks on / 4 weeks off
  • 4 weeks (full baseline)
  • Yes. Extended reset allows complete receptor normalization
  • Chronic stress models, extended observation periods
  • Preferred for multi-cycle studies requiring consistent cycle-to-cycle response
  • 8 weeks on / 1 week off
  • 1 week (insufficient)
  • No. Receptors remain partially downregulated
  • Not recommended
  • Produces diminishing returns after week 5; subsequent cycles show reduced efficacy
  • Continuous (no washout)
  • None
  • No. Progressive receptor desensitization
  • Observable effects plateau by week 6; ongoing administration wastes compound without additional benefit
  • The table above reflects cycle structures we've reviewed across institutional peptide research protocols. The 4/2 and 6/4 structures preserve receptor sensitivity across multiple cycles, making them suitable for longitudinal studies. Continuous administration and insufficient washout structures consistently underperform after the first cycle.
More references

Related material